InSysBio announces its participation in the 14th Annual World Bispecific Summit which is to be held on October 2-4, 2023 at Boston Park Plaza, Boston, MA. Oleg Demin Jr, Scientific Director, QSP modeling in Oncology & Immuno-Oncology, InSysBio will give a talk within its frames
InSysBio announces its participation in the 31st PAGE Meeting 2023 which is to be held at the Palexco Convention and Exhibition Centre, A Coruna, Spain on June 28-30, 2023. InSysBio team presents a poster within its frames
IRT Onco version is focused on tumor-specific immune response
InSysBio launches the Oncology version of Immune Response Template (IRT). IRT in Oncology represents a QSP platform of immune system in cancer, simultaneously being a tool for development of QSP and mechanistic models related to tumor-specific immune response.
InSysBio announces the start of operation of Headquarters in the United Kingdom. At the same time, the new branch office has been founded in Cyprus and part of InSysBio team has relocated there, thus, expanding the company’s presence.
By using our website, you agree to data collection as described in our website’s data collection policy.